XML 24 R33.htm IDEA: XBRL DOCUMENT v3.2.0.727
SHAREHOLDERS' EQUITY (Tables)
 6 Months Ended
Jun. 30, 2015
Stockholders' Equity Note [Abstract]  
Schedule of Shareholders' equity
 
Valeant Pharmaceuticals International, Inc. Shareholders
 
 
 
 
 
Common Shares
 
Additional
Paid-In
Capital
 
Accumulated
Deficit
 
Accumulated
Other
Comprehensive
Loss
 
Valeant
Pharmaceuticals
International, Inc.
Shareholders’
Equity
 
Noncontrolling
Interest
 
Total
Equity
 
Shares
 
Amount
 
 
 
 
 
 
Balance, January 1, 2014
333.0

 
$
8,301.2

 
$
228.8

 
$
(3,278.5
)
 
$
(132.8
)
 
$
5,118.7

 
$
114.6

 
$
5,233.3

Common shares issued under share-based compensation plans
0.8

 
24.7

 
(17.5
)
 
—

 
—

 
7.2

 
—

 
7.2

Settlement of stock options
—

 
—

 
(3.1
)
 
—

 
—

 
(3.1
)
 
—

 
(3.1
)
Share-based compensation
—

 
—

 
40.4

 
—

 
—

 
40.4

 
—

 
40.4

Employee withholding taxes related to share-based awards
—

 
—

 
(36.5
)
 
—

 
—

 
(36.5
)
 
—

 
(36.5
)
Tax benefits from stock options exercised
—

 
—

 
1.2

 
—

 
—

 
1.2

 
—

 
1.2

Acquisition of noncontrolling interest
—

 
—

 
(1.1
)
 
—

 
—

 
(1.1
)
 
(2.2
)
 
(3.3
)
 
333.8

 
8,325.9

 
212.2

 
(3,278.5
)
 
(132.8
)
 
5,126.8

 
112.4

 
5,239.2

Comprehensive income:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income (loss)
—

 
—

 
—

 
103.2

 
—

 
103.2

 
(1.5
)
 
101.7

Other comprehensive income (loss)
—

 
—

 
—

 
—

 
28.1

 
28.1

 
(1.7
)
 
26.4

Total comprehensive income
 
 
 
 
 
 
 
 
 
 
131.3

 
(3.2
)
 
128.1

Balance, June 30, 2014
333.8

 
$
8,325.9

 
$
212.2

 
$
(3,175.3
)
 
$
(104.7
)
 
$
5,258.1

 
$
109.2

 
$
5,367.3

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance, January 1, 2015
334.4

 
$
8,349.2

 
$
243.9

 
$
(2,365.0
)
 
$
(915.9
)
 
$
5,312.2

 
$
122.3

 
$
5,434.5

Issuance of common stock (see below)
7.5

 
1,481.0

 
—

 
—

 
—

 
1,481.0

 
—

 
1,481.0

Common shares issued under share-based compensation plans
1.1

 
57.0

 
(34.9
)
 
—

 
—

 
22.1

 
—

 
22.1

Repurchases of common shares
(0.2
)
 
(6.4
)
 
—

 
(43.6
)
 
—

 
(50.0
)
 
—

 
(50.0
)
Share-based compensation
—

 
—

 
60.9

 
—

 
—

 
60.9

 
—

 
60.9

Employee withholding taxes related to share-based awards
—

 
—

 
(61.5
)
 
—

 
—

 
(61.5
)
 
—

 
(61.5
)
Tax benefits from stock options exercised
—

 
—

 
25.6

 
—

 
—

 
25.6

 
—

 
25.6

Noncontrolling interest distributions
—

 
—

 
—

 
—

 
—

 
—

 
(1.1
)
 
(1.1
)
 
342.8

 
9,880.8

 
234.0

 
(2,408.6
)
 
(915.9
)
 
6,790.3

 
121.2

 
6,911.5

Comprehensive loss:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income (loss)
—

 
—

 
—

 
20.7

 
—

 
20.7

 
2.2

 
22.9

Other comprehensive loss
—

 
—

 
—

 
—

 
(375.6
)
 
(375.6
)
 
(0.4
)
 
(376.0
)
Total comprehensive loss
 
 
 
 
 
 
 
 
 
 
(354.9
)
 
1.8

 
(353.1
)
Balance, June 30, 2015
342.8

 
$
9,880.8

 
$
234.0

 
$
(2,387.9
)
 
$
(1,291.5
)
 
$
6,435.4

 
$
123.0

 
$
6,558.4